HHS Sec. Azar on Drug Price Disclosure and 'Broken' Obamacare Market

The video discusses the U.S. government's initiative to require pharmaceutical companies to disclose drug list prices in TV ads, aiming to create transparency and potentially lower drug costs. It covers the legal challenges faced by this regulation, including questions of authority and constitutionality. The video also examines the current state of the Affordable Care Act, highlighting efforts to stabilize and improve it under the Trump administration. Finally, it explores strategies to reduce healthcare costs by focusing on value-based care and bipartisan efforts to reform the system.

What changes have been observed in the Affordable Care Act under the current administration compared to the previous one?

How does the administration plan to ensure that people with pre-existing conditions are protected in any future healthcare legislation?

What initiatives are being proposed to bend the cost curve of medical care in the country?